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Purpose: Caffeic acid phenethyl ester (CAPE), an active component of honeybee propolis, has a wide range of beneficial
properties. The purpose of this study was to test the protective role of CAPE in 661W cells (in vitro) against H2O2-mediated
cell death and in albino rats (in vivo) against various light conditions.
Methods: The 661W cells were pretreated with CAPE and then stressed with H2O2. Cell death was measured with lactate
dehydrogenase (LDH) release assay, and mRNA and proteins were analyzed. Sprague Dawley rats were raised on either
a control or CAPE (0.02%) diet and exposed to various light conditions for short or long periods. Retinal histology, mRNA,
protein, lipid composition, and retinal function by electroretinography (ERG) were measured at the end of feeding.
Results: Pretreatment of 661W cells with CAPE reduced H2O2-mediated cell death in a dose-dependent manner and
induced expression of heme oxygenase-1 (Ho1). Albino rats fed with CAPE had greater expression of Ho1 and intercellular
adhesion molecule 1 (Icam1), less expression of FOS-like antigen (Fosl) and lipoxygenase 12 (Lox12) genes in the retina,
less translocation of nuclear factor kappaB protein to the nucleus, and a lower molar ratio of n-3 polyunsaturated fatty
acids. Further, the ERGs of the retinas of CAPE-fed rats were significantly higher than those of the control-fed rats when
raised in dim light.
Conclusions: CAPE can activate the antioxidative gene expression pathway in retinal cells in vitro and in vivo. Feeding
CAPE to albino rats can enhance ERG responses and change the lipid profile in the rats’ retinas.
Retinal  degenerations  are  a  heterogeneous  group  of
diseases in which the light-sensitive photoreceptor cells and
their supporting retinal pigment epithelium (RPE) cells die
irreversibly. Mutations in as many as 150 genes have been
found for the monogenic forms of these diseases. A complex
inheritance  pattern  and  environmental  factors,  such  as
exposure to light, combine for the complex etiology as in the
cases  of  age-related  macular  degeneration  [1-3].
Accumulating evidence suggests that excessive exposure to
white light [4-6], oxidative damage (free radicals) [7-10], and
inflammatory  stresses  [7,11]  are  some  of  the  common
pathogenic factors in the development of age-related macular
degeneration [7,12] and progression of retinitis pigmentosa
[13].
Caffeic  acid  phenethyl  ester  (CAPE)  is  an  active
component of honeybee propolis. CAPE has been used in
Asian and Ayurvedic folk medicine since ancient times [14].
In the past three decades, several studies have shown that
CAPE has a wide range of beneficial properties, including
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antioxidant,  anti-inflammatory,  antiproliferative,  antiviral,
antibacterial, and immunomodulatory properties [15-18]. The
prominent protective property of CAPE makes it a potential
therapeutic compound against damage for the heart [19-21],
kidney [22-24], and other tissues or organs [25,26]. Recently,
CAPE has been found to have a protective role in neurons or
neural tissues. CAPE can block apoptosis in cerebellar granule
cells  [27],  suppress  ischemia-reperfusion-induced  cerebral
injury [28] and spinal cord ischemia/reperfusion injury [29],
and  prevent  various  toxin-induced  neurodegeneration  or
neurotoxicity [30-34].
Since  CAPE  has  well  known  anti-inflammatory  and
antioxidant properties, we hypothesize that CAPE may be able
to protect retinal cells against oxidative and inflammatory
stress-induced damage and can be used as an augmentative
therapy  for  preventing  or  delaying  the  onset  of  retinal
degeneration in humans. In this study, we used the H2O2-
mediated cell death model of mouse photoreceptor-derived
661W cells and acute or chronic bright light-induced retinal
degeneration models of albino Sprague Dawley (SD) rats to
test the protective role of CAPE in vitro and in vivo.
METHODS
Cell culture: Mouse photoreceptor-derived 661W cells [35]
were kindly provided by Dr. Muayyad Al-Ubaidi (University
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1325of Oklahoma Health Sciences Center, Oklahoma City, OK).
The  661W  cells  were  maintained  in  Dulbecco's  modified
Eagle's  medium  (DMEM;  Invitrogen,  Carlsbad,  CA).  The
medium contained 10% fetal bovine serum, 1 mM sodium
pyruvate,  100  units/ml  penicillin,  and  100  μg/ml
streptomycin. The cells were grown in 5% CO2, and 95%
humidity at 37 °C.
Cell viability assays: The 661W cells (4×106) were cultured
for  24  h  in  10  ml  medium  in  10-cm  plates.  To  test  the
cytoprotective effect of CAPE against H2O2-mediated cell
death, the cells were pretreated for 3 h with 1 to 20 μM of
CAPE (Cat# Q-2305; Bachem Americas Inc., Torrance, CA).
The cells were then washed. Fresh medium was added to the
cells, and 3 h later the cells were stressed with 1 mM of
H2O2 (Sigma, St. Louis, MO) for another 6 h. Cell viability
was determined indirectly by measuring the released lactate
dehydrogenase (LDH) in the medium by using a commercial
kit from Promega (CytoTox-ONE Homogenous Membrane
Integrity  Assay  kit;  Madison,  WI)  following  the
manufacturer's instructions. For the LDH release assay, the
fluorescence measure of the release of LDH from the cells
with a damaged membrane was calculated by subtracting the
culture medium background, and the cell viability (%) was
calculated from 100% viability (mean value of untreated cells)
to 0% viability (mean value of 2% Triton X-100-treated cells,
Sigma, St. Louis, MO). To isolate the RNA and proteins,
661W cells were scrapped from the 10-cm dishes, washed
twice  with  RNase-free  ice-cold  phosphate-buffered  saline
(PBS), and collected with centrifugation. The cell pellets were
stored at −80 °C until the RNA and proteins were extracted.
Animal care: All procedures were performed according to the
Association  for  Research  in  Vision  and  Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vision
Research and the University of Oklahoma Health Sciences
Center (OUHSC) Guidelines for Animals in Research. All
protocols were reviewed and approved by the Institutional
Animal Care and Use Committees of the OUHSC and the
Dean A. McGee Eye Institute.
Dietary supplementation of caffeic acid phenethyl ester and
the design for light exposure to retina:
Acute light stress and short-term dim light exposure
—This study was performed by feeding six-week-old rats on
either CAPE or control diets (n=8 in each group) in cyclic dim
light (DL: 50 lux, 7 AM to 7 PM), and then exposing them to
acute light stress. Briefly, pelleted CAPE and control diets
were prepared by Dyets Inc. (Bethlehem, PA). Rats were
housed four to a cage, and the diets were supplied on top of
the cage cover. Water was provided ad libitum. SD rats were
fed either with the AIN-93G diet (Control diet: Cont) or the
AIN-93G  diet  supplemented  with  0.02%  CAPE  (w/w;
Bachem  Americas  Inc.;  CAPE  diet:  CAPE).  Based  on
published literature, to supply 10–20 mg/kg/day CAPE, the
CAPE concentration was 0.02% in the diet [36-41]. When
administered  intravenously,  1–10  mg/kg  CAPE  has  been
shown to cross the blood–brain barrier and protect the rat brain
after transient focal cerebral ischemia in a dose-dependent
manner  [42];  we  speculated  dietary  CAPE  can  also  be
absorbed, transported through blood, and can reach the retina
by crossing the blood–retinal barrier. After two weeks of
feeding, two groups (CAPE and Cont) were kept in cyclic dim
light; the other two groups (CAPE and Cont) were exposed to
intense bright light at 2,700 lux for 6 h (acute light stress
group).  After  intense  light  exposure,  these  groups  were
returned to their native dim cyclic light and fed their respective
diets. Retinal function was measured with electroretinography
(ERG) after one week of light damage. Then the rats were
euthanized  with  CO2  from  a  compressed  gas  tank  in  an
euthanization chamber followed by cervical dislocation, and
their eyeballs were harvested for retinal histological analysis.
Chronic (long-term) dim or bright light exposure—
Three-week-old (immediately after weaning) rats (12 rats per
group) were fed either with an AIN-93G diet (Cont) or an
AIN-93G diet supplemented with 0.02% CAPE (CAPE) in
cyclic dim light (DL: 50 lux, 7 AM to 7 PM) for eight weeks.
Additional three-week-old rats (12 rats per group) were fed
with either the Cont diet or the CAPE diet and exposed to
cyclic bright light (BL: 200 lux, 7 AM to 7 PM) for eight
weeks to test the effect of CAPE on rat retinas by raising the
rats  in  higher  intensity  cyclic  light.  Retinal  function  was
measured at the end of eight weeks without any further light
treatment. Immediately after the ERG was measured, the rats
were  euthanized,  the  right  eyeballs  were  processed  for
quantitative morphology, and the neural retina from the left
eye was harvested and stored in −80 °C for RNA, protein
extraction, and fatty acid analysis.
Electroretinography: Flash ERGs were recorded with an ERG
recording  system  (Espion  E2  ERG  System;  Diagnosys,
Lowell,  MA).  Rats  were  maintained  in  total  darkness
overnight and prepared for ERG recording in dim red light.
Each  rat  was  anesthetized  with  ketamine  (120  mg/kg
bodyweight  intramuscularly)  and  xylazine  (6  mg/kg
bodyweight,  intramuscularly).  One  drop  of  10%
phenylephrine was applied to the cornea to dilate the pupil,
and one drop of 0.5% proparacaine HCl was applied for local
anesthesia. A reference electrode was positioned in the mouth
and a ground electrode on the foot, and the rat was placed
inside a Ganzfeld illuminating sphere with a gold electrode
placed on the cornea. Four increasing strobe flashes were used
starting at an intensity of −2.3 followed by −1.3, 0.7, and 2.7
log cd.s/m2, and the ERG responses from both eyes were
recorded to assess rod photoreceptor function (scotopic ERG).
To evaluate cone function (photopic ERG), a strobe flash
stimulus (3.7 log cd.s/m2) was presented to dilated, light-
adapted (5 min at 2.0 log cd.s/m2) rats. The amplitude of the
A-wave was measured from the prestimulus baseline to the
A-wave trough. The amplitude of the B-wave was measured
from the trough of the A-wave to the peak of the B-wave.
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ERG was recorded, the animals were euthanized with CO2
asphyxiation  in  an  euthanization  chamber  followed  by
cervical dislocation, and eyeballs were removed, fixed, and
embedded  in  paraffin.  Sections  (5  μm  thick)  were  taken
through the optic nerve head along the vertical meridian to
compare all regions of the retina in the superior and inferior
hemispheres.  In  each  hemisphere,  the  outer  nuclear  layer
(ONL) thickness was measured at 480-μm intervals in seven
defined areas, starting at the optic nerve head and extending
toward the superior and inferior ora serrata. In addition, the
mean ONL thickness was calculated for the inferior and the
superior regions of each retina.
Retinal  fatty  acid  analysis:  Whole  neural  retinas  were
harvested from rats fed either the Cont or CAPE diet and
frozen immediately in liquid nitrogen. Retinal lipids were
subsequently extracted with a modified Bligh–Dyer technique
[43] in the presence of internal standards. In brief, the lipids
from one retina were extracted in a Teflon/glass homogenizer
using  2  ml  of  methanol/chloroform  (1:1,  v/v)  with  phase
separation with the addition of 1.5 ml of saline. The methanol/
chloroform  mixture  contained  the  following  internal
standards: di-14:0 phosphatidylethanolamine (PE; 23.6 nM),
di-17:0 PE (23.6 nM), di-20:0 phosphatidylcholine (PC; 11.8
nM), and di-14:0 phosphatidylserine (PS; 1.8 nM). Lipids
were  extracted  twice  from  the  retinas,  and  the  pooled
chloroform layers were washed with the Folch theoretical
upper phase before the solvent evaporated under a nitrogen
stream and the layers were resuspended in chloroform [44].
For fatty acid composition analysis, fatty acid methyl
esters were prepared from the total retinal lipid extracts by
subjecting them to strong acid hydrolysis (16.6% HCL in
methanol at 75 °C overnight) as described by Agbaga et al.
[44]. The fatty acid methyl esters were separated from other
sterols with thin layer chromatography and analyzed with a
gas  chromatography-flame  ionization  detector  (Agilent
Figure 1. Caffeic acid phenethyl ester (CAPE) protects 661W cells
from oxidant-induced cell death. 661W cells were pretreated in situ
with 1 to 20 μM CAPE for 3 h. After thorough washing, cells were
exposed to 1 mM H2O2 for 6 h. Cell death was then measured by
analyzing the release of lactate dehydrogenase (LDH; n=4 plate × 4
replication assay). (*: p<0.01; **: p<0.001; by one way ANOVA)
TABLE 1. SEQUENCE OF THE PRIMERS USED FOR RT–PCR.
Gene Forward Primer (5′-3′) Reverse Primer (5′-3′)
Ho1 TCTATCGTGCTCGCATGAAC CTGTCTGTGAGGGACTCTGG
Icam1 TCAAACGGGAGATGAATGGT AGTTTTAGGGCCTCCTCCTG
Thx1 GTGTGGACCTTGCAAAATGA CCCAACCTTTTGACCCTTTT
Nrf2 AGGACATGGAGCAAGTTTGG TCCTCAAAACCATGAAGGAA
Cxcl1 TAGCCACACTCAAGAATGGT CTCCATTACTTGGGGACACC
Lox5 ACCTGACGGTGGTGATCTTC GGCCACGGTCTGGTAGAGTA
Lox12 GCACAGCTCTGCCATTTCCT GATGGTCATCTGCAGACAGG
NfKb1 ACAGATGGGCTACACAGAGG TGTCTCCACACCACTGTCAC
EGR1 CTACGAGCACCTGACCACAG AGGCCACTGACTAGGCTGAA
iNos AGGTGCACACAGGCTACTCC GGCCACCAGCTTCTTCAA
Tnf-a CTCAAAACTCGAGTGACAAGC GTGGGTGAGGAGCACGTAGT
Fosl1 AGAGCGGAACAAGCTAGCAG CAAGTACGGGTCCTGGAGAA
C-fos GAAACGGAGAATCCGAAGG TGGGCTGCCAAAATAAACTC
Catalase GCGCTTCAACAGTGCTAATG AGGGTGGACGTCAGTGAAAT
Cox2 GGCACCAATGATACTGAAGC TCAGAGCATTGGCCATAGAA
IL6 TGTGCAATGGCAATTCTGAT GGAAGTTGGGGTAGGAAGGA
Ccl2 GTTAATGCCCCACTCACCTG TTCCTTATTGGGGTCAGCAC
Hgprt1 CTTTGCTGACCTGCTGGATTAC TTGGGGCTGTACTGCTTAACC
RPL19 GGGAAGAGGAAGGGTACTGC GGACGCTTCATTTCTTGGTC
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1327Technologies, Santa Clara, CA) as described in Ford et al.
[45].
RNA  isolation,  cDNA  synthesis,  and  quantitative  reverse-
transcriptase polymerase chain reaction: RNA was isolated
and purified from frozen cultured 661W cells and rat retinas
using the PureLink Micro-to-Midi Total RNA Purification
System  from  Invitrogen  following  the  manufacturer's
protocol. Equal quantities (1.0 μg) of total RNA from each
tissue were converted to first-strand cDNA using SuperScript
III First-Strand Synthesis SuperMix (Invitrogen) for reverse-
transcriptase  polymerase  chain  reaction  (RT–PCR).  First-
strand cDNA was used for quantitative reverse-transcriptase
PCR (qRT–PCR). Primers for qRT–PCR were designed in
such  a  way  that  they  spanned  at  least  one  intron,  which
eliminated the chance of amplification from residual genomic
DNA  contamination.  The  primer  sequences  are  provided
(Table 1). Quantitative PCR and melt-curve analyses were
performed  using  iQ  SYBR  Green  Supermix  (Bio-Rad,
Hercules,  CA)  and  an  iCycler  machine  (Bio-Rad).  The
relative quantities of the expression of the genes of interest in
different samples were calculated with the comparative Ct
(threshold cycle) value method [46].
Western blotting: Whole-cell lysates from the 661W cells and
the retinal extracts were prepared for western blotting by
sonicating in T-PER reagent (Pierce, Rockford, IL) containing
a protease inhibitor cocktail (Roche, Indianapolis, IN) and
then centrifuging at 10,000× g for 15 min at 4 °C to collect
the  supernatants.  After  the  protein  concentrations  were
determined using BCA reagent (Pierce), equal aliquots (20–
30  μg)  of  protein  samples  were  applied  to  10%  sodium
dodecyl  sulfate  polyacrylamide  gels  (Invitrogen)  and
electrophoretically  separated.  Resolved  proteins  were
electrophoretically transferred to nitrocellulose membranes
(Bio-Rad) and blocked with 5% nonfat dry milk for 1 h at
room temperature. The membranes were incubated with anti-
HO-1  (1:1,000;  R&D  Systems,  Minneapolis,  MN),  anti-
cyclooxygenase-2 (COX-2; 1:1,000; Cayman Chemical, Ann
Arbor, MI), anti-lipoxygenase 5 (LOX5) (1:1,000; Cayman
Chemical), anti-nuclear factor-kappaB (NFκB; 1:1,000; Santa
Cruz Bio, Santa Cruz, CA), anti-I kappaB-alpha (1:1,000;
Santa  Cruz),  anti-phospho-I  kappaB-alpha  (1:1,000;  Santa
Cruz),  or  anti-β-actin  (1:2,000;  Abcam,  Cambridge,  MA)
antibodies for 16 h at 4 °C, after which they were incubated
with the appropriate peroxidase-linked secondary antibody
for 1 h at room temperature. Chemiluminescence signals were
developed  with  the  SuperSignal  West  Femto
Chemiluminescent Substrate (Pierce), and the signals were
detected with a digital imaging system (IS4000R; Kodak,
New Haven, CT). The intensities of the protein bands were
determined using ImageJ 1.32j software.
Statistical analyses: Statistical analyses were performed by
using GraphPad Prism 5.0 software (GraphPad Software Inc.,
La Jolla, CA). The quantitative data are expressed as mean
±standard deviation (SD) or standard error of the mean (SEM)
for each group. An unpaired Student t test was performed for
the means of two unmatched groups; for three or more groups,
one-way ANOVA was used to compare each pair of the test
groups.
RESULTS
The cytoprotective effect of caffeic acid phenethyl ester in
661W cells: The 661W cells were pretreated with varied doses
Figure 2. Gene expression in 661W cells
was  measured  by  quantitative  reverse
transcriptase  PCR  (qRT–PCR).  Gene
expression  was  analyzed  with  the
comparative  Ct  value  method  after
normalizing  against  the  housekeeping
gene, Rpl19. Expression values (±SD)
are presented against fold change over
no-treatment value, which was set to 1.0
(n=3 samples ×3 replication assay per
sample).  No  treatment:  no  treatment
with CAPE or H2O2; H2O2:treated with
1  mM  of  H2O2  for  6  h;  caffeic  acid
phenethyl ester (CAPE): treated with 5
μM  CAPE  for  3  h;  H2O2  +  CAPE:
treated with 5 μM CAPE for 3 h, and
then treated with 1 mM of H2O2 for 6 h
(*: p<0.05; **: p<0.01, by the Student
t test).
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3 h, and then challenged the cells with 1 mM H2O2 for 6 h.
This oxidant challenge caused 27% cell death. Pretreatment
with CAPE reduced the cell death in a dose-dependent manner
up to 5 μM (Figure 1). The cells were then harvested and
extracted the mRNA and proteins. An analysis was conducted
for the expression of the genes involved in oxidative stress
and  the  proteins  involved  in  apoptotic  and  protective
signaling.
Gene expression in 661W cells: Expression of a series of genes
that includes the antioxidant pathway and survival pathway
were analyzed from the CAPE-treated 661W cells by using
qRT–PCR.  The  expression  data  were  analyzed  with  the
comparative Ct value method after normalizing against the
housekeeping  gene,  60S  Ribosomal  protein  L19  (Rpl19).
Compared to the cells with no treatment, cells pretreated with
CAPE for 3 h had significantly induced expression of the
heme oxygenase 1 (Ho1) gene (Figure 2, 30 fold, p<0.01).
These cells also had significantly induced expression of FOS-
like antigen 1 (Fosl1) by 70% (p<0.05), chemokine (C-X-C
motif)  ligand  1  (Cxcl1)  by  threefold  (p<0.01),  and
lipoxygenase  12  (Lox12;  p<0.05);  however,  early  growth
response  1  (Egr1)  expression  decreased  significantly  by
twofold (p<0.01).
Treatment with 1 mM H2O2 for 6 h slightly induced the
expression  of  Ho1,  intercellular  adhesion  molecule  1
(Icam1), Lox12, Egr1, and apoptotic gene Fosl1 (Figure 2).
However, pretreatment of CAPE significantly reduced the
expression of the Icam1, Egr1, Cxcl1, and Fosl1 genes (Figure
2).
Protein expression of heme oxygenase 1, cyclooxygenase-2,
and IkappaB-alpha in 661W cells: The expression of select
Figure 4. Retinal function measured by electroretinography (ERG)
in rats fed for three weeks under cyclic dim (50 lx) light. Scotopic
ERG-A (absolute value) and B wave amplitude were analyzed from
the rats fed for three weeks with CAPE and reared under dim cyclic
light. CAPE-A: A wave from rats fed by CAPE diet; CONT-A: A
wave from rats fed by control diet; CAPE-B: B wave from rats fed
by CAPE diet; and CONT-B: B wave from rats fed by control diet.
(n=8/ group; *: p<0.01, **: p<0.001, with the Student t test).
Figure 3. Expression and quantification of selected proteins in 661W cells treated with caffeic acid phenethyl ester (CAPE) and H2O2. A:
Expression and quantification of heme oxygenase 1 (HO-1), cyclooxygenase 2 (COX-2), and IκBα proteins in 661W cells was measured by
western blot analysis. Proteins were extracted and subjected to western blotting with anti-HO-1, anti-COX-2, and anti-IκBα antibodies. Lane
1(NT): no treatment; lanes 2 and 3 (caffeic acid phenethyl ester [CAPE]): CAPE treated; lanes 4 and 5 (H2O2): H2O2 treated; lanes 6 and 7
(C+H): pretreated with CAPE, then with H2O2. B: Quantification of COX-2 and IκBα in 661W cells with western blotting. Quantification of
COX-2 and IκBα was obtained with densitometric analysis, and normalized with β-actin. (n=3–6; *: p<0.05, by the Student t test).
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signaling  was  assayed.  As  shown  by  the  gene  expression
studies,  treatment  of  CAPE  alone  induced  HO-1  protein
expression to a significant level (Figure 3A), and interestingly
CAPE action on HO-1 protein persisted even after 6 h of
treatment with 1 mM H2O2 (Figure 3A: C+H). In addition, the
level  of  COX-2,  an  inducible  enzyme  that  acts  as  a
dioxygenase,  a  peroxidase,  and  a  potent  mediator  of
inflammation, increased (Figure 3A). Quantification analysis
showed  the  COX-2  protein  expression  increased  about
twofold upon treatment with CAPE (p<0.05, Figure 3B), and
remained high even when treated with H2O2.
On the other hand, IκBα expression decreased with CAPE
treatment but returned to normal levels when treated with
H2O2 (Figure 3A,B). With a phosphospecific antibody, no
phosphorylation was detected in this protein in any of the
treatment groups (data not shown), indicating NFκB signaling
is probably suppressed or not involved in this scenario. These
results  support  the  notion  that  CAPE  could  activate  the
Figure  5.  Retina  outer  nuclear  layer
(ONL) thickness from rats fed for three
weeks under cyclic dim light. The ONL
thickness  measured  in  μM  at  each
defined area from superior to inferior
through  optic  nerve.  There  is  no
significant difference in ONL thickness
of caffeic acid phenethyl ester (CAPE)-
fed  retina  and  control-fed  retina
(p>0.05, with the Student t test; n=8).
Cont+DL: control diet under cyclic dim
light;  CAPE+DL:  CAPE  diet  under
cyclic dim light.
Figure 6. Retinal function measured by
electroretinography  (ERG)  in  rats  fed
for eight weeks and maintained under
cyclic dim or bright light. A: Scotopic
ERG-A and B wave amplitudes of rats
fed for eight weeks and maintained in
cyclic dim light (DL, 50 lux; n=12; one-
way ANOVA). B: Scotopic ERG-A and
B wave amplitudes of rats fed for eight
weeks and maintained in cyclic bright
light  (BL,  200  lux;  n=12;  one-way
ANOVA).  CONT+DL:  Rats  fed  with
control diet and maintained under cyclic
dim  (50  lux)  light  for  eight  weeks;
CAPE+DL: Rats fed with CAPE diet
and  maintained  under  cyclic  dim
(50 lux) light for eight weeks; CONT
+BL:  Rats  fed  with  control  diet  and
maintained under cyclic bright (200 lux)
light for eight weeks; CAPE+BL: Rats
fed  with  CAPE  diet  and  maintained
under cyclic bright (200 lux) light for
eight  weeks.  (n=12;  *:  p<0.01,  **:
p<0.001, one-way ANOVA).
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related genes and proteins in the retina-derived 661W cells.
Functional  evaluation  with  electroretinography  and
morphologic  evaluation  with  quantitative  histology:  To
understand CAPE’s role in the retina in vivo, the SD rats’ diet
was  supplemented  with  CAPE,  and  then  the  rats  were
subjected to either acute intense light stress or chronic cyclic
dim/bright  light  exposure  and  their  retinas  analyzed  from
structural, functional, and biochemical standpoints. Feeding
rats with a 0.02% CAPE diet for two weeks did not protect the
retinas from intense-light-induced damage (2,700 lux for 6 h,
data not shown). Interestingly, compared to the rats fed with
the control diet, the CAPE-fed rats maintained in dim light
(DL; 50 lux for 3 weeks, 7 AM to 7 PM) had significantly
higher ERG scotopic A and B wave amplitudes (Figure 4);
however,  no  significant  difference  was  observed  in  the
photopic ERG (data not shown) or in the photoreceptor cell
numbers (measured by ONL thickness; Figure 5).
Figure  7.  Cone  photoreceptor  function  was  measured  by
electroretinography (ERG) after eight weeks of feeding with control
and caffeic acid phenethyl ester (CAPE) diet. Cone photoreceptor
function was measured with single-flash photopic ERG with a flash
stimulus of 3.7 log cd.s/m2 that was presented to dilated, light-
adapted  (5  min  at  2.0  log  cd.s/m2)  rats.  There  is  no  significant
difference (n=12/group) observed in cone function among the rats
fed with CAPE and reared in different light conditions. Cont+DL:
control diet under cyclic dim light; CAPE+DL: CAPE diet under
cyclic dim light; Cont+BL: control diet under cyclic bright light;
CAPE+BL: CAPE diet under cyclic bright light.
To further confirm the enhanced ERG responses from rats
fed  with  CAPE  in  cyclic  dim  light,  the  rat  number  was
increased from eight to 12 in each group, and the duration of
the feeding period was increased from three weeks to eight
weeks in cyclic dim light (50 lux). Another group that was fed
for eight weeks with CAPE and exposed to bright cyclic light
(200 lux) was established to determine whether CAPE can
protect the retina from cyclic-bright-light-induced, chronic
photoreceptor loss. Similar to the three-week feeding results
(Figure  4),  the  eight-week  CAPE  feeding  resulted  in
significantly higher ERG responses in the dim-reared rats
(scotopic  A  and  B;  p<0.01;  Figure  6A).  However,  no
significant difference was observed in the ERG responses
between the CAPE- and control-fed rats maintained in bright
cyclic light (200 lux) for eight weeks (Figure 6B). The cone
response  as  measured  with  photopic  ERG,  and  the  ONL
thicknesses were still not significantly different between the
CAPE- and the control-fed rats under cyclic dim or bright light
(Figure 7 and Figure 8). The retinas were further examined
using biochemical and molecular analyses to understand the
effect of dietary CAPE on retinal tissue, with a focus on
oxidative and inflammatory markers.
Gene and protein expression in the retina: The expression of
a series of genes known to be involved in oxidative stress and
proinflammatory  processes,  including  Ho1,  Icam1,  Cox2,
Catalase,  Cxcl1,  Lox5,  Lox12,  Ccl2,  Fosl,  interleukin-6
(IL6), c-Fos, thioredoxin 1 (Thx1), Nfkb, and glial fibrillary
acidic  protein  (Gfap),  were  measured  in  the  retinas  from
CAPE-fed rats maintained in either dim or bright cyclic light
for eight weeks. All expression values were normalized to the
housekeeping gene, Rpl19.
Compared to the retinas from rats fed with the control diet
in  DL,  the  retinas  from  the  CAPE-fed  rats  in  DL  had
significantly  higher  expression  levels  of  Ho1  and  Icam1
(p<0.05) and significantly lower expression levels of Fosl1
(proapoptotic) and Lox12 (proinflammatory) (2.5-fold and
one-fold, respectively, p<0.05 for each, Figure 9). However,
no significant differences were found in the expression of
Cox2, catalase, Cxcl1, Lox5, Ccl2, IL6, C-fos, Thx1, Nfkb, and
Gfap.
In addition, the NFκB protein level in the nuclear fraction
was significantly lower in the retinas from CAPE-fed rats
under cyclic dim light than in the retinas from rats fed the
control diet, but the protein levels of LOX5, COX-2, and
cytosolic NFκB were not different between the two groups
(Figure 10A,B).
However, no significant differences were detected in the
expression levels of the Ho1, Icam1, Cox2, catalase, Cxcl1,
Lox5, Lox12, Ccl2, Fosl, IL6, C-fos, Thx1, Nfkb, and Gfap
genes and the LOX5, COX-2, and NFκB proteins in nuclear
and cytoplasmic fractions from the retinas of rats maintained
under cyclic BL for eight weeks (Figure 9, Figure 10A,B).
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1331Fatty  acid  analysis:  Since  CAPE  can  inhibit  lipid
peroxidation [47] and lipoxygenase activities [48], it may
affect fatty acid metabolism in the retina. The fatty acid profile
in the retinas from rats fed with the CAPE or control diet for
eight weeks that were maintained either in cyclic dim or bright
light were analyzed. Compared to the control-fed rats, the
CAPE-fed rats maintained in dim cyclic light had significantly
higher relative mole percentages of the fatty acids 14:0, 18:1,
and 18:3n3 and the ratio of n6/n3-fatty acids (p<0.05), and
significantly lower the fatty acids 18:0, 20:2n6, 20:4n6, 22:0,
22:1, 22:4n6, 22:6n3 (docosahexaenoic acid), 24:0, 24:1, and
24:6n3 (p<0.05) (Table 2). However, for the rats maintained
under bright cyclic light no changes were detected (p>0.05),
except for significantly higher relative mole percentages of
22:1, 22:5n3, and 24:1 fatty acids in the CAPE-fed rats than
in the control-fed rats (p<0.05, Table 2).
Figure 8. Measurement of retina outer
nuclear layer (ONL) thickness from rats
fed  for  eight  weeks  with  control  and
caffeic  acid  phenethyl  ester  (CAPE)
diet. The ONL thickness measured in
μM  at  each  defined  area  from  the
superior to the inferior through the optic
nerve. There is no significant difference
between  the  ONL  thickness  of  the
caffeic acid phenethyl ester (CAPE)-fed
retina and the control-fed retina either
from  cyclic  dim  light  (DL)  or  from
cyclic  bright  light  (BL)  (n=12/group;
p>0.05,  with  the  Student  t  test).
However, bright light rearing reduced
the  ONL  thickness  significantly  from
dim light rearing. Cont+DL: control diet
under  cyclic  dim  light;  CAPE+DL:
CAPE diet under cyclic dim light; Cont
+BL:  control  diet  under  cyclic  bright
light;  CAPE+BL:  CAPE  diet  under
cyclic bright light.
Figure 9. Expression of selected genes
in rat retina as measured by quantitative
reverse transcriptase PCR (qRT–PCR).
Retinas  were  harvested  from  rats
maintained under cyclic dim or bright
light  exposure  for  eight  weeks.
Expression  values  were  normalized
with  the  housekeeping  gene,  Rpl19.
Expression values (±SD) are presented
as  fold  change  over  the  CONT+DL
value,  which  was  set  to  1.0  (n=4
samples).  CONT+DL:  control  diet
under  cyclic  dim  light;  caffeic  acid
phenethyl  ester  (CAPE)+DL:  CAPE
diet under cyclic dim light; CONT+BL:
control  diet  under  cyclic  bright  light;
CAPE+BL:  CAPE  diet  under  cyclic
bright light. (*: p<0.05, with the Student
t test).
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1332DISCUSSION
The cytoprotective mechanism of CAPE as determined by
several studies is multioriented. CAPE is a potent and specific
inhibitor  for  suppressing  NFκB  activation  [49],  lipid
peroxidation  [47],  lipoxygenase  activities  [48],  protein
tyrosine  kinase  activity  [50],  and  ornithine  decarboxylase
activity [51]. We found that CAPE protected retina-derived
661W cells against H2O2-induced cell death in vitro, which
was accompanied by changes in the expression of a series of
antioxidant genes and proteins. Supplementation with CAPE
in the diet can also modulate the expression of a series of
antioxidant genes and proteins in albino rat retinas.
Although the molecular mechanism of the cytoprotective
role of CAPE in retinal cells is not known, our data suggest
Figure 10. Expression and quantification of selected proteins in the retina from rats fed for eight weeks with control and caffeic acid phenethyl
ester (CAPE) diet. Retinas were harvested from CAPE- and control diet-fed rats maintained under cyclic dim or bright light exposure for eight
weeks. A: Retinal whole cell proteins were extracted and subjected to western blotting with anti-LOX5, and anti-COX-2 antibodies, and the
cytoplasmic and nuclear fraction separately with anti-NFκB antibodies. B: Quantification of LOX5, COX-2, and NFκB (n) expression in
nuclei and NFκB (c) in cytosol from the retinas was obtained with densitometric analysis, and normalized by β-actin, (n=4). Cont+DL: control
diet under cyclic dim light; CAPE+DL: CAPE diet under cyclic dim light; Cont+BL: control diet under cyclic bright light; CAPE+BL: CAPE
diet under cyclic bright light. (*: p<0.05, with the Student t test).
TABLE 2. RELATIVE MOLE PERCENTAGE (±SD) OF FATTY ACID COMPOSITION FROM RAT RETINA FED BY CAPE OR CONTROL DIET UNDER DIM
OR BRIGHT CYCLIC LIGHT REARING.
 
Under dim light (DL)   Under bright light (BL)    
Fatty acid CONT+DL CAPE+DL p-value CONT+BL CAPE+BL p-value
14:0 0.96± 0.06 1.68±0.28 <0.05 0.94±0.11 0.84±0.04 0.4
18:0 17.97±0.29 13.28±1.49 <0.05 18.64±1.57 20.10±0.09 0.3
18:1 15.84±0.28 19.37±1.49 <0.05 16.38±1.08 15.35±0.12 0.3
18:2n6 9.05±0.51 13.27±2.05 0.07 8.46±1.44 6.80±0.08 0.22
18:3n6 0.08±0.00 0.09±0.01 0.39 0.08±0.01 0.07±0.00 0.45
18:3n3 0.60±0.04 1.13±0.19 <0.05 0.53±0.16 0.35±0.01 0.22
20:2n6 0.47±0.03 0.35±0.02 <0.05 0.43±0.06 0.49±0.02 0.39
20:4n6 9.71±0.48 7.58±0.83 0.06 10.61±0.68 11.43±0.46 0.37
22:0 0.30±0.01 0.22±0.02 <0.05 0.35±0.04 0.40±0.01 0.23
22:1 0.03±0.00 0.02±0.00 <0.05 0.03±0.00 0.05±0.00 <0.05
22:4n6 0.65±0.09 0.29±0.04 <0.05 0.35±0.02 0.35±0.02 0.97
22:5n3 0.67±0.06 0.56±0.07 0.27 0.55±0.01 0.72±0.02 <0.05
22:6n3 15.53±0.28 10.38±1.97 <0.05 14.41±1.07 15.00±0.78 0.68
24:0 0.45±0.02 0.32±0.03 <0.05 0.53±0.04 0.58±0.02 0.34
24:1 0.33±0.03 0.23±0.01 <0.05 0.34±0.02 0.40±0.01 <0.05
24:6n3 0.24±0.00 0.16±0.03 <0.05 0.17±0.01 0.16±0.02 0.69
n6/n3 1.16±0.06 1.82±0.26 <0.05 1.27±0.12 1.18±0.09 0.59
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1333that CAPE may act through inhibiting NFκB [49]. Activation
of NFκB, known to act as a master regulator for the expression
of  many  genes,  may  induce  the  apoptotic  process.  In  the
cytosol, NFκB remains inactive by forming a complex with
inhibitory  proteins  of  IκBα.  In  response  to  stimuli,  IκBα
kinases  (IκKs)  mediate  IκBα  phosphorylation,  the
dissociation  of  the  NFκB  inhibitory  complex,  and  the
activation of NFκB, which then translocates to the nucleus
[52,53].  Activation  and  nuclear  localization  of  the
transcription  factor  NFκB  are  reportedly  found  in  light-
stressed retinas from mice and may play a role in light-induced
photoreceptor degeneration [54,55]. In our study, we observed
not only reduced IκBα expression in the CAPE-treated 661W
cells  (Figure  3A,B)  but  also  a  significant  decrease  in  the
amount of NFκB translocated to the nucleus in the retinas of
CAPE-fed rats (Figure 10A). This observation is consistent
with observations from previous studies; inhibiting NFκB
activation by CAPE may be a mechanism of CAPE-mediated
anti-inflammatory and antioxidation effects [23].
Emerging evidence suggests that CAPE may also act
through inducing the heme oxygenase 1 system to manifest
antioxidant characteristics [56-59]. HO-1 is a ubiquitous and
redox-sensitive, inducible stress protein [60]. HO-1 catalyzes
the degradation of heme to generate carbon monoxide, free
ferrous iron, and biliverdin [61]. Further data supported a
pivotal role for HO-1 in the resolution of acute inflammatory
states [62], as well as a role in protecting against oxidative
stress [63,64]. We found dramatic increases in the gene and
protein expression of HO-1 in the 661W cells treated with
CAPE for 3 h (Figure 2 and Figure 3A), and increased gene
expression in the retinas of rats fed with CAPE and maintained
under cyclic dim light (Figure 9). These data further support
the action of CAPE as an inducer of HO-1 to represent an
efficient antioxidant system and a potential pharmacological
target for a variety of oxidant- and inflammatory-mediated
diseases,  including  brain  aging  and  neurodegenerative
disorders [65-69].
We  also  found  CAPE  treatment  downregulated  the
oxidant-induced expression of Egr1 and Icam1 in 661W cells.
EGR1, a Zn2+ finger-containing transcription factor, is known
as a mediator of oxidative stress-induced tissue damage and
controls  the  expression  of  many  inflammatory  genes,
including Icam1 [70,71]. The CAPE-mediated decrease in
Egr1 and Icam1 expression levels in 661W cells indicates its
anti-inflammatory activity may also be mediated through the
EGR1  transcription  factor.  An  induction  of  COX-2  was
recorded in the CAPE-treated 661W cells and in the cells
treated with CAPE and H2O2 (Figure 3B). However, in the
retina treated with CAPE under either dim or bright light the
COX-2 level did not change. It could be a hormetic response
in the cultured 661W cells, in which CAPE induced slight
inflammatory stress to the cells, which in turn activated a
cellular protective system, such as induction of HO-1 gene
expression.  Further  studies  are  needed  to  understand  this
response.
Interestingly, we found that dietary supplementation of
CAPE  enhanced  the  amplitudes  of  ERG  A  and  B  wave
responses (Figure 4, Figure 6A) in dim-reared rats, which is
a novel observation. However, how CAPE influenced the
scotopic ERG responses is not clear. Along with the enhanced
ERG amplitudes, we found significant changes in a series of
fatty acids in the retinas from the CAPE-fed rats. The retinas
from  CAPE-fed  and  cyclic  dim  light-maintained  rats  had
higher molar ratios of 14:0, 18:1, and 18:3n3 fatty acids and
a lower content of 22:6n3 and 18:0, 20:2n6, 20:4n6, 22:0,
22:1, 22:4n6, 24:0, 24:1, and 24:6n3 fatty acids (Table 2). We
speculate that altered fatty acid composition in the retinas of
the CAPE-fed rats probably contributed to the higher ERG
responses. In the 1970s, Anderson et al. found that fatty acid
composition in rod outer segment membranes is an important
determinant  for  optimal  retinal  function  in  rodents  and
alterations  are  associated  with  modifications  of  retinal
function as measured with ERG [72,73]. Later, many studies
reported  that  alterations  in  fatty  acids,  especially
docosahexaenoic  acid  content  and  altered  n6/n3,  are
associated with altered phototransduction efficiency and thus
ERG responses [74-78]. Further, the rats maintained under
bright (200 lux) cyclic light for eight weeks had no significant
changes in the fatty acid levels or the n6/n3 ratio and no
significant change in ERG responses, which provides further
support  to  our  hypothesis  that  the  altered  fatty  acid
composition of the retina may be associated with altered ERG
responses  (Table  2  and  Figure  6A,B).  Previous  studies
reported that natural compounds, such as ginseng extract and
saffron, could alter (enhance) the ERG responses in animal
models and in humans by some unknown mechanism [79,
80].
Although CAPE changed the fatty acid profile in the
retina, how CAPE affects the fatty acid profile in the retina is
unclear. Since CAPE is a potent and specific inhibitor of lipid
peroxidation [48] and can inhibit lipoxygenase 5 [47] and
lipoxygenase  15  [81],  we  speculate  that  the  modulated
lipoxygenase activity by CAPE in the retina might partially
contribute  to  the  altered  fatty  acid  composition.  Further
experiments are needed to clarify these probable pathways.
Finally, we did not find that CAPE protected the retina
from damage induced by acute bright light (2700 lux for 6 h)
and chronic bright light (200 lux for 8 weeks). This might be
due to the low amount of CAPE (0.02%) present in the diet,
such that the amount that was absorbed and reached the retina
might not be enough to protect against strong insults such as
2,700 lux light for 6 h or 200 lux cyclic light for eight weeks.
The  bioavailability  of  CAPE  through  diet  and  its
transportation  to  the  retina,  therefore,  needs  further
investigation.
In conclusion, we found CAPE activated the antioxidant
gene expression pathway in 661W cells and in rat retinas, and
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1334enhanced the scotopic ERG A/B wave amplitude and altered
fatty acid profile in the retinas of rats maintained under cyclic
dim light. These data support further investigation into the
potential therapeutic benefits of CAPE in protecting the retina
from oxidative and/or inflammatory stress.
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